Rationalizing the heart failure trials: from theory to practice

    Research output: Contribution to journalArticle

    8 Citations (Scopus)

    Abstract

    It is 10 years since the CONSENSUS I study showed that ACE inhibitors improved mortality in heart failure. This finding has been confirmed in numerous trials, for example SOLVD, SAVE. Indeed, in the intervening 10 years, many other potential therapies have been examined in mortality trials, but so far no other therapy has had as good effect on mortality as ACE inhibitors. The other therapies which have been examined are digoxin, amlodipine, beta-blockers, amiodarone, etc. Despite ACE inhibitors being a very effective therapy for heart failure, there is still remarkable under-use of them in clinical practice. The reason for this needs to be explained further, but fear of hypothermia and renal dysfunction appear to be major factors.
    Original languageEnglish
    Pages (from-to)5-8
    Number of pages4
    JournalEuropean Heart Journal
    Volume18
    Issue numberSuppl E
    DOIs
    Publication statusPublished - 1997

    Fingerprint Dive into the research topics of 'Rationalizing the heart failure trials: from theory to practice'. Together they form a unique fingerprint.

  • Cite this